Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories (Q43064192)
Jump to navigation
Jump to search
scientific article published on 13 May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories |
scientific article published on 13 May 2010 |
Statements
1 reference
Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories (English)
1 reference
M Fiegl
1 reference
M Erdel
1 reference
I Tinhofer
1 reference
Y Brychtova
1 reference
A Panovska
1 reference
M Doubek
1 reference
K Eigenberger
1 reference
C Fonatsch
1 reference
G Hopfinger
1 reference
H Mühlberger
1 reference
A Zabernigg
1 reference
F Falkner
1 reference
G Gastl
1 reference
J Mayer
1 reference
R Greil
1 reference
Austrian Collaborative Study Group on Alemtuzumab in Chronic Lymphocytic Leukemia, in cooperation with The Czech Leukemia Study Group for Life, CELL
1 reference
13 May 2010
1 reference
1 reference
21
1 reference
12
1 reference
2410-2419
1 reference
Identifiers
1 reference
1 reference